Discovery of novel potential 11β-HSD1 inhibitors through combining deep learning, molecular modeling, and bio-evaluation (original) (raw)

References

  1. Visockiene Z, Brimas G, Abaliksta T, Siauliene L, Liakina V, Strupas K (2013) Metabolic changes one year after laparoscopic adjustable gastric banding operation in morbidly obese subjects. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive Techniques 8(1):13–21
    PubMed Google Scholar
  2. Asbaghi O, Emamat H, Kelishadi MR, Hekmatdoost A (2020) The association between nuts intake and non-alcoholic fatty liver disease (NAFLD) risk: a case-control study. Clin Nutr Res 9(3):195–204
    Article PubMed PubMed Central Google Scholar
  3. Mora-Janiszewska O, Faryniak-Zuzak A, Darmochwał-Kolarz D (2022) Epigenetic links between microbiota and gestational diabetes. Int J Mol Sci 23(3)
  4. Onyekwere CA, Ogbera AO, Samaila AA, Balogun BO, Abdulkareem FB (2015) Nonalcoholic fatty liver disease: synopsis of current developments. Niger J Clin Pract 18(6):703–712
    Article CAS PubMed Google Scholar
  5. Chiang JI, Jani BD, Mair FS, Nicholl BI, Furler J, O’Neal D, Jenkins A, Condron P, Manski-Nankervis JA (2018) Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: a systematic review. PLoS ONE 13(12):e0209585
    Article CAS PubMed PubMed Central Google Scholar
  6. Wan ZK, Chenail E, Xiang J, Li HQ, Ipek M, Bard J, Svenson K, Mansour TS, Xu X, Tian X, Suri V, Hahm S, Xing Y, Johnson CE, Li X, Qadri A, Panza D, Perreault M, Tobin JF, Saiah E (2009) Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model. J Med Chem 52(17):5449–5461
    Article CAS PubMed Google Scholar
  7. Pasieka AM, Rafacho A (2016) Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence. Metabolites 6(3)
  8. Peng K, Pan Y, Li J, Khan Z, Fan M, Yin H, Tong C, Zhao Y, Liang G, Zheng C (2016) 11β-Hydroxysteroid dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes. Sci Rep 6:37160
    Article CAS PubMed PubMed Central Google Scholar
  9. Nakata T, Fujita A, Umeda M, Yoshida H, Inami K, Masuzaki H, Sawai H (2016) The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity. Springerplus 5:40
    Article PubMed PubMed Central Google Scholar
  10. Chuanxin Z, Shengzheng W, Lei D, Duoli X, Jin L, Fuzeng R, Aiping L, Ge Z (2020) Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases: a comprehensive guide to their chemical structure diversity in drug development. Eur J Med Chem 191:112134
    Article PubMed Google Scholar
  11. Ovens AJ, Gee YS, Ling NXY, Yu D, Hardee JP, Chung JD, Ngoei KRW, Waters NJ, Hoffman NJ, Scott JW, Loh K, Spengler K, Heller R, Parker MW, Lynch GS, Huang F, Galic S, Kemp BE, Baell JB, Oakhill JS, Langendorf CG (2022) Structure-function analysis of the AMPK activator SC4 and identification of a potent pan AMPK activator. Biochem J 479(11):1181–1204
    Article CAS PubMed Google Scholar
  12. Jeong IK (2012) The role of cortisol in the pathogenesis of the metabolic syndrome. Diabetes Metab J 36(3):207–210
    Article PubMed PubMed Central Google Scholar
  13. Venier O, Pascal C, Braun A, Namane C, Mougenot P, Crespin O, Pacquet F, Mougenot C, Monseau C, Onofri B, Dadji-Faïhun R, Leger C, Ben-Hassine M, Van-Pham T, Ragot JL, Philippo C, Farjot G, Noah L, Maniani K, Boutarfa A, Nicolaï E, Guillot E, Pruniaux MP, Güssregen S, Engel C, Coutant AL, de Miguel B, Castro A (2013) Discovery of SAR184841, a potent and long-lasting inhibitor of 11β-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D. Bioorg Med Chem Lett 23(8):2414–2421
    Article CAS PubMed Google Scholar
  14. Wang L, Liu J, Zhang A, Cheng P, Zhang X, Lv S, Wu L, Yu J, Di W, Zha J, Kong X, Qi H, Zhong Y, Ding G (2012) BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice. PLoS ONE 7(7):e40056
    Article CAS PubMed PubMed Central Google Scholar
  15. Hardy RS, Botfield H, Markey K, Mitchell JL, Alimajstorovic Z, Westgate CSJ, Sagmeister M, Fairclough RJ, Ottridge RS, Yiangou A, Storbeck KH, Taylor AE, Gilligan LC, Arlt W, Stewart PM, Tomlinson JW, Mollan SP, Lavery GG, Sinclair AJ (2021) 11βHSD1 inhibition with AZD4017 improves lipid profiles and lean muscle mass in idiopathic intracranial hypertension. J Clin Endocrinol Metab 106(1):174–187
    Article PubMed Google Scholar
  16. He J, Nittinger E, Tyrchan C, Czechtizky W, Patronov A, Bjerrum EJ, Engkvist O (2022) Transformer-based molecular optimization beyond matched molecular pairs. J Cheminformatics 14(1):18
    Article CAS Google Scholar
  17. Beltzung B, Pelé M, Renoult JP, Sueur C (2023) Deep learning for studying drawing behavior: a review. Front Psychol 14:992541
    Article PubMed PubMed Central Google Scholar
  18. Liu X, Ye K, van Vlijmen HWT, Emmerich MTM, IJzerman AP, van Westen GJP (2021) DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology. J Cheminformatics 13(1):85
    Article CAS Google Scholar
  19. Wu F, Xu T, He G, Ouyang L, Han B, Peng C, Song X, Xiang M (2012) Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking. Int J Mol Sci 13(12):15668–15678
    Article CAS PubMed PubMed Central Google Scholar
  20. Puranik NV, Srivastava P, Bhatt G, John Mary DJS, Limaye AM, Sivaraman J (2019) Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach. Sci Rep 9(1):7450
    Article PubMed PubMed Central Google Scholar
  21. Tokalı FS, Taslimi P, Tuzun B, Karakuş A, Sadeghian N, Gulçin İ (2023) Novel quinazolinone derivatives: potential synthetic analogs for the treatment of glaucoma, Alzheimer’s disease and diabetes mellitus. Chem Biodivers 20(10):e202301134
    Article PubMed Google Scholar
  22. Shamsuddin MA, Ali AH, Zakaria NH, Mohammat MF, Hamzah AS, Shaameri Z, Lam KW, Mark-Lee WF, Agustar HK, Mohd Abd Razak MR, Latip J, Hassan NI (2021) Synthesis, molecular docking, and antimalarial activity of hybrid 4-aminoquinoline-pyrano[2,3-c]pyrazole derivatives. Pharmaceuticals (Basel, Switzerland) 14(11)
  23. Ma L, Li R, Yao Z, Wang B, Liu Y, Liu C, Wang H, Chen S, Sun D (2022) Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK). Aging 14(20):8394–8410
    CAS PubMed PubMed Central Google Scholar
  24. Huang Z, Chavda VP, Vora LK, Gajjar N, Apostolopoulos V, Shah N, Chen ZS (2022) 2-Deoxy-D-Glucose and its derivatives for the COVID-19 treatment: an update. Front Pharmacol 13:899633
    Article CAS PubMed PubMed Central Google Scholar
  25. Kumar R, Kumar A, Långström B, Darreh-Shori T (2017) Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening. Sci Rep 7(1):16287
    Article PubMed PubMed Central Google Scholar
  26. Qin W, Li YH, Tong J, Wu J, Zhao D, Li HJ, Xing L, He CX, Zhou X, Li PQ, Meng G, Wu SP, Cao HL (2021) Rational design and synthesis of 3-morpholine linked aromatic-imino-1H-indoles as novel Kv15 channel inhibitors sharing vasodilation effects. Front Mol Biosci 8:805594
    Article CAS PubMed Google Scholar
  27. Wu N, Feng Z, He X, Kwon W, Wang J, Xie XQ (2019) Insight of captagon abuse by chemogenomics knowledgebase-guided systems pharmacology target mapping analyses. Sci Rep 9(1):2268
    Article PubMed PubMed Central Google Scholar
  28. Bello M, Martínez-Muñoz A, Balbuena-Rebolledo I (2020) Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA. J Mol Model 26(12):340
    Article CAS PubMed PubMed Central Google Scholar
  29. Kongsompong S, E-kobon T, Taengphan W, Sangkhawasi M, Khongkow M, Chumnanpuen P (2023) Computer-aided virtual screening and in vitro validation of biomimetic tyrosinase inhibitory peptides from abalone peptidome. Int J Mol Sci 24(4)
  30. Zhang Z, Xu Y, Wu J, Shen Y, Cheng H, Xiang Y (2019) Exploration of the selective binding mechanism of protein kinase Aurora A selectivity via a comprehensive molecular modeling study. PeerJ 7:e7832
    Article PubMed PubMed Central Google Scholar
  31. Dean M, Austin J, Jinhong R, Johnson ME, Lantvit DD, Burdette JE (2018) The flavonoid apigenin is a progesterone receptor modulator with in vivo activity in the uterus. Hormones Cancer 9(4):265–277
    Article CAS PubMed PubMed Central Google Scholar
  32. Socher E, Heger L, Paulsen F, Zunke F, Arnold P (2022) Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike—ACE2 complexes reveal distinct changes between both variants. Comput Struct Biotechnol J 20:1168–1176
    Article CAS PubMed PubMed Central Google Scholar
  33. de Oliveira OV, Rocha GB, Paluch AS, Costa LT (2021) Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. J Biomol Struct Dyn 39(11):3924–3933
    Article PubMed Google Scholar
  34. Lu J, Wang C, Ma Y, Liu K, Fu X, Xing S (2023) Exploration of the product specificity of chitosanase CsnMY002 and mutants using molecular dynamics simulations. Molecules (Basel, Switzerland) 28(3)
  35. Chen S, He Y, Geng Y, Wang Z, Han L, Han W (2021) Molecular dynamic simulations of bromodomain and extra-terminal protein 4 bonded to potent inhibitors. Molecules (Basel, Switzerland) 27(1)
  36. Guo HB, Perminov A, Bekele S, Kedziora G, Farajollahi S, Varaljay V, Hinkle K, Molinero V, Meister K, Hung C, Dennis P, Kelley-Loughnane N, Berry R (2022) AlphaFold2 models indicate that protein sequence determines both structure and dynamics. Sci Rep 12(1):10696
    Article CAS PubMed PubMed Central Google Scholar
  37. Avti P, Chauhan A, Shekhar N, Prajapat M, Sarma P, Kaur H, Bhattacharyya A, Kumar S, Prakash A, Sharma S, Medhi B (2022) Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings. J Biomol Struct Dyn 40(19):8894–8904
    Article CAS PubMed Google Scholar
  38. Xu Z, Liu D, Liu D, Ren X, Liu H, Qi G, Zhou Y, Wu C, Zhu K, Zou Z, Yuan J (2022) Equisetin is an anti-obesity candidate through targeting 11β-HSD1. Acta Pharmaceutica Sinica B 12(5):2358–2373
    Article CAS PubMed PubMed Central Google Scholar
  39. Chai Y, Zhao M (2017) iTRAQ-Based quantitative proteomic analysis of the inhibitory effects of polysaccharides from Viscum coloratum (Kom.) Nakai on HepG2 cells. Sci Rep 7(1):4596
  40. Zhu YH, Ye N, Tang XF, Khan MI, Liu HL, Shi N, Hang LF (2019) Synergistic effect of retinoic acid polymeric micelles and prodrug for the pharmacodynamic evaluation of tumor suppression. Front Pharmacol 10:447
    Article CAS PubMed PubMed Central Google Scholar
  41. Xu Z, Liu D, Liu D, Ren X, Liu H, Qi G, Zhou Y, Wu C, Zhu K, Zou Z, Yuan J, Lin W, Guo P (2022) Equisetin is an anti-obesity candidate through targeting 11β-HSD1. Acta pharmaceutica Sinica B 12(5):2358–2373
    Article CAS PubMed PubMed Central Google Scholar
  42. Yin R, Qiu C, Shen Q, Wang Z (2022) Corin is regulated by circ-0012397/miR-200a-3p and inhibits the oxygen-glucose deprivation-induced apoptosis of SHSY5Y neuroblastoma cells. Ann Transl Med 10(22):1242
    Article CAS PubMed PubMed Central Google Scholar
  43. Sun D, Wang Z, Di Y, Jaen JC, Labelle M, Ma J, Miao S, Sudom A, Tang L, Tomooka CS, Tu H, Ursu S, Walker N, Yan X, Ye Q, Powers JP (2008) Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). Bioorg Med Chem Lett 18(12):3513–3516
    Article CAS PubMed Google Scholar

Download references